Ian Anderson
ORCID: 0000-0003-2205-9209Also affiliated with University of Manchester, South Eastern Sydney Local Health District, University of Glasgow, The University of Texas at Austin
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 6 papers. Top paper: “Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial”.
Marina Chiara Garassino, Heather A. Wakelee, Moïshe Liberman, Terufumi Kato, Masahiro Tsuboi +91 more
Courtney Worrell, Melisa Kose, Ian Anderson, Bruno Aouizerate, Volker Arolt +56 more
Mathilde Antoniades, Guray Erus, José García, Yong Fan, Danilo Arnone +44 more
Guray Erus, Yong Fan, Mathilde Antoniades, Danilo Arnone, Stephen R. Arnott +44 more
Guray Erus, Yong Fan, Mathilde Antoniades, Danilo Arnone, Stephen R. Arnott +44 more
Cynthia H.Y. Fu, Guray Erus, José García, Yong Fan, Danilo Arnone +43 more